Drug Test 10 Panel $2.59 to $3.89 Instant Pro Screen Kit FDA/CLIA Cleared

Low as $2.59 each, $3.89 each with 1-9 Screen Order. FDA Approved, CLIA Waived Our 10 Panel Multi-Drug Screen Urine Discard is a professional, forensic, all-inclusive, point-of-use screening test for the rapid detection of 1 Phencyclidine (PCP), 2 Opiates OPI, 3 MDMA Ecstasy, 4 Methamphetamine (MET/mAMP), 5 Amphetamine (AMP), 6 Methadone (MTD), 7 Marijuana (THC), 8 Cocaine (COC), 9 Benzodiazepines (BZO), 10 Barbiturates (BAR), in human urine at or above the system concentrations levels establish...

Low as $2.59 each, $3.89 each with 1-9 Screen Order. FDA Approved, CLIA Waived Our 10 Panel Multi-Drug Screen Urine Discard is a professional, forensic, all-inclusive, point-of-use screening test for the rapid detection of 1 Phencyclidine (PCP), 2 Opiates OPI, 3 MDMA Ecstasy, 4 Methamphetamine (MET/mAMP), 5 Amphetamine (AMP), 6 Methadone (MTD), 7 Marijuana (THC), 8 Cocaine (COC), 9 Benzodiazepines (BZO), 10 Barbiturates (BAR), in human urine at or above the system concentrations levels established as standard minimums by the National Institute on Drug Abuse (NIDA), the World Health Organization (WHO) and SAMHSA. Urine-based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of lateral flow-based immunoassays identical to that employed in our 10 Panel Multi-Drug of Abuse Test have made them the most widely accepted method for screening urine for drugs of abuse. Our 10 Panel Multi-Drug Screen Urine Dip Card is based on the principle of the highly specific immunochemical reactions of antigens and antibodies which are used for the analysis of specific compounds in human urine. Our 10-Panel Multi-Drug Screen is a rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of the ten (10) targeted drugs and their metabolites listed above. This 10 Panel Multi-Drug Screen Urine Dip Card is intended as an initial forensic screen for the presence of drug or drug metabolites at the time the test is performed.